The Business Research Company's Global Hutchinson-Gilford Progeria Syndrome Market Outlook 2025-2034: Growth Drivers, Share, And Trends It will grow to $149.22 billion in 2029 at a compound annual ...
Cao K, Graziotto JJ, Blair CD, Mazzulli JR. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci Transl Med. 2011 Jun 29;3(89 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback